Intralesion and Curaderm<sup>BEC5</sup> Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

International Journal of Clinical Medicine

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

Google-based Impact Factor: 0.52
Citations h5-index & Ranking

Journals Menu

"Intralesion and Curaderm^BEC5 Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared"
written by Bill E. Cham,
published by International Journal of Clinical Medicine, Vol.3 No.2, 2012

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma
	Clin Med Rev Case Rep, 2022

[2]	Breeding and Genome Mapping for Resistance to Biotic Stress in Eggplant
	Genomic Designing for …, 2022

[3]	Metabolomic Analysis of Phytochemical Compounds from Agricultural Residues of Eggplant (Solanum melongena L.)
	Angulo, A Moreno-Ulloa… - Molecules, 2022

[4]	Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma
	2020

[5]	First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm: A Case Report
	2020

[6]	Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
	2020

[7]	Solasodine: A Perspective on their roles in Health and Disease
	2019

[8]	Follow Blog via Email
	2018

[9]	Natural substances for cancer prevention
	2018

[10]	Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
	2017

[11]	A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
	2015

[12]	A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
	Journal of Cancer Treatment and Research, 2015

[13]	A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
	2015

[14]	Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
	Journal of Cancer Therapy, 2015

[15]	Glycoalkaloid isolation from Solanum linnaeanum berries
	Fruits, 2015

[16]	A standardized plant extract containing a target compound is acceptable as a potent therapeutic entity: Relevance to BEC and solamargine, a topical clinical …
	2015

[17]	Chemical synthesis of saponins
	2014

[18]	Eggplant
	Alien Gene Transfer in Crop Plants, Volume 2, 2014

[19]	Synthesis and cytotoxic effect of pseudodiosgenyl saponins with thio-ring F
	Bioorganic & medicinal chemistry letters, 2014

[20]	Alien Gene Transfer in Crop Plants, Volume
	Springer-Verlag New York, 2014

[21]	Alien Gene Transfer in Crop Plants, Volume 2: Achievements and Impacts
	2014

[22]	Alien Gene Transfer in Crop Plants, Volume 2
	Springer-Verlag New York, 2014

[23]	A Review of Solasodine Rhamnosides Therapy for In-Situ Squamous Cell Carcinoma on the Penis.
	British Journal of Medicine and Medical Research, 2014

[24]	Alien Gene Transfer in Crop Plants, Volume 1: Innovations, Methods and Risk Assessment
	Springer-Verlag New York, 2013

[25]	Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
	2013

[26]	Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
	International Journal of Clinical Medicine, 2013

[27]	Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5
	Journal of Cancer Therapy, 2013

[28]	Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm BEC5
	2013

[29]	Topical Curaderm BEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
	2013

[1]	Compendium of Crop Genome Designing for Nutraceuticals 2023 DOI:10.1007/978-981-19-3627-2_53-1

[2]	Compendium of Crop Genome Designing for Nutraceuticals 2023 DOI:10.1007/978-981-19-4169-6_53

[3]	Metabolomic Analysis of Phytochemical Compounds from Agricultural Residues of Eggplant (Solanum melongena L.) Molecules, 2022 DOI:10.3390/molecules27207013

[4]	Genomic Designing for Biotic Stress Resistant Vegetable Crops 2022 DOI:10.1007/978-3-030-97785-6_4

[5]	Advances in Carbohydrate Chemistry and Biochemistry, 2021 DOI:10.1016/bs.accb.2021.10.001

[6]	Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies International Journal of Clinical Medicine, 2017 DOI:10.4236/ijcm.2017.812064

[7]	Glycoalkaloid isolation fromSolanum linnaeanumberries Fruits, 2015 DOI:10.1051/fruits/2015037

[8]	Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities Journal of Cancer Therapy, 2015 DOI:10.4236/jct.2015.612114

[9]	Alien Gene Transfer in Crop Plants, Volume 2 2014 DOI:10.1007/978-1-4614-9572-7_16

[10]	Synthesis and cytotoxic effect of pseudodiosgenyl saponins with thio-ring F Bioorganic & Medicinal Chemistry Letters, 2014 DOI:10.1016/j.bmcl.2014.01.055

[11]	Advances in Carbohydrate Chemistry and Biochemistry, 2014 DOI:10.1016/B978-0-12-800128-8.00002-9

[12]	Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with Curaderm^BEC5 Journal of Cancer Therapy, 2013 DOI:10.4236/jct.2013.42076

[13]	Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents Modern Chemotherapy, 2013 DOI:10.4236/mc.2013.22005

[14]	Topical Curaderm^BEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes International Journal of Clinical Medicine, 2013 DOI:10.4236/ijcm.2013.45041

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

International Journal of Clinical Medicine

International Journal of Clinical Medicine

Journals Menu

Home

About SCIRP

Service

Policies